Objective:To study the therapeutic efficiency of vascular endothelia growth factor 165(VEGF_(165)) and Angiopoietin 1 (Ang1) gene injection on myocardial ischemia.

• 目的探讨血管内皮生长因子165(VEGF_(165))和血管生成素1(Angiopoietin-1,Ang1)基因导入对心肌缺血的治疗作用。